Download PDF
CC BY 4.0 · Surg J (N Y) 2017; 03(01): e25-e31
DOI: 10.1055/s-0037-1599273
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Treatment Options in Gastrointestinal Cutaneous Fistulas

Itamar Ashkenazi
1   Department of Surgery, Hillel Yaffe Medical Center, Hadera, Israel
,
Fernando Turégano-Fuentes
2   Department of Emergency Surgery, Hospital General Universitario Gregorio Marañon, Madrid, Spain
,
Oded Olsha
3   Department of Surgery, Shaare Zedek Medical Center, Jerusalem, Israel
,
Ricardo Alfici
1   Department of Surgery, Hillel Yaffe Medical Center, Hadera, Israel
› Author Affiliations
Further Information

Publication History

12 July 2016

25 January 2017

Publication Date:
14 March 2017 (online)

   Permissions and Reprints

Abstract

Enterocutaneous fistulas occur most commonly following surgery. A minority of them is caused by a myriad of other etiologies including infection, malignancy, and radiation. While some fistulas may close spontaneously, most patients will eventually need surgery to resolve this pathology. Successful treatment entails adoption of various methods of treatment aimed at control of sepsis, protection of surrounding skin and soft tissue, control of fistula output, and maintenance of nutrition, with eventual spontaneous or surgical closure of the fistula. The aim of this article is to review the various treatment options in their appropriate context.

Keywords

fistula - intestinal fistula - enterocutaneous fistula
 

  • References

  • 1 Lynch AC, Delaney CP, Senagore AJ, Connor JT, Remzi FH, Fazio VW. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg 2004; 240 (05) 825-831
    CrossrefPubMedGoogle Scholar
  • 2 Martinez JL, Luque-de-Leon E, Mier J, Blanco-Benavides R, Robledo F. Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes. World J Surg 2008; 32 (03) 436-443 , discussion 444
    CrossrefPubMedGoogle Scholar
  • 3 Schecter WP, Ivatury RR, Rotondo MF, Hirshberg A. Open abdomen after trauma and abdominal sepsis: a strategy for management. J Am Coll Surg 2006; 203 (03) 390-396
    CrossrefPubMedGoogle Scholar
  • 4 Schecter WP, Hirshberg A, Chang DS. , et al. Enteric fistulas: principles of management. J Am Coll Surg 2009; 209 (04) 484-491
    CrossrefPubMedGoogle Scholar
  • 5 Subramaniam MH, Liscum KR, Hirshberg A. The floating stoma: a new technique for controlling exposed fistulae in abdominal trauma. J Trauma 2002; 53 (02) 386-388
    CrossrefPubMedGoogle Scholar
  • 6 Alfici R, Ashkenazi I, Kessel B, Zut N, Sternberg A. Temporary bowel diversion using the Bogotá bag (Hadera stoma): technical details. J Am Coll Surg 2004; 199 (02) 344-346
    CrossrefPubMedGoogle Scholar
  • 7 Al-Khoury G, Kaufman D, Hirshberg A. Improved control of exposed fistula in the open abdomen. J Am Coll Surg 2008; 206 (02) 397-398
    CrossrefPubMedGoogle Scholar
  • 8 Kearney R, Payne W, Rosemurgy A. Extra-abdominal closure of enterocutaneous fistula. Am Surg 1997; 63 (05) 406-409
    PubMedGoogle Scholar
  • 9 Layton B, Dubose J, Nichols S, Connaughton J, Jones T, Pratt J. Pacifying the open abdomen with concomitant intestinal fistula: a novel approach. Am J Surg 2010; 199 (04) e48-e50
    CrossrefPubMedGoogle Scholar
  • 10 Dumanian GA, Llull R, Ramasastry SS, Greco RJ, Lotze MT, Edington H. Postoperative abdominal wall defects with enterocutaneous fistulae. Am J Surg 1996; 172 (04) 332-334
    CrossrefPubMedGoogle Scholar
  • 11 Cheong EC, Ong WC, Lim TC, Lim J. Successful split-thickness skin grafting in a contaminated wound with an enterocutaneous fistula. Plast Reconstr Surg 2005; 115 (04) 1221-1222
    CrossrefPubMedGoogle Scholar
  • 12 Erdmann D, Drye C, Heller L, Wong MS, Levin SL. Abdominal wall defect and enterocutaneous fistula treatment with the Vacuum-Assisted Closure (V.A.C.) system. Plast Reconstr Surg 2001; 108 (07) 2066-2068
    CrossrefPubMedGoogle Scholar
  • 13 Cro C, George KJ, Donnelly J, Irwin ST, Gardiner KR. Vacuum assisted closure system in the management of enterocutaneous fistulae. Postgrad Med J 2002; 78 (920) 364-365
    CrossrefPubMedGoogle Scholar
  • 14 Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg 1997; 38 (06) 563-576 , discussion 577
    CrossrefPubMedGoogle Scholar
  • 15 Rao M, Burke D, Finan PJ, Sagar PM. The use of vacuum-assisted closure of abdominal wounds: a word of caution. Colorectal Dis 2007; 9 (03) 266-268
    CrossrefPubMedGoogle Scholar
  • 16 Fischer JE. A cautionary note: the use of vacuum-assisted closure systems in the treatment of gastrointestinal cutaneous fistula may be associated with higher mortality from subsequent fistula development. Am J Surg 2008; 196 (01) 1-2
    CrossrefPubMedGoogle Scholar
  • 17 Hougaard HT, Ellebaek M, Holst UT, Qvist N. The open abdomen: temporary closure with a modified negative pressure therapy technique. Int Wound J 2014; 11 (Suppl. 01) 13-16
    CrossrefPubMedGoogle Scholar
  • 18 Goverman J, Yelon JA, Platz JJ, Singson RC, Turcinovic M. The “Fistula VAC,” a technique for management of enterocutaneous fistulae arising within the open abdomen: report of 5 cases. J Trauma 2006; 60 (02) 428-431 , discussion 431
    CrossrefPubMedGoogle Scholar
  • 19 Verhaalen AL, Wiegelt JA, Brasel KJ. Isolation of an enterocutaneous fistula within a vacuum-assisted wound closure system: new help for a difficult problem. General Surgery News 2006 ;volume 33:08, issue 8. accessed online at http://www.generalsurgerynews.com/Procedure-Update/Article/08-06/Isolation-of-an-Enterocutaneous-Fistula-Within-a-Vacuum-Assisted-Wound-Closure-System-/5164
    PubMedGoogle Scholar
  • 20 de Weerd L, Kjaeve J, Aghajani E, Elvenes OP. The sandwich design: a new method to close a high-output enterocutaneous fistula and an associated abdominal wall defect. Ann Plast Surg 2007; 58 (05) 580-583
    CrossrefPubMedGoogle Scholar
  • 21 Wainstein DE, Fernandez E, Gonzalez D, Chara O, Berkowski D. Treatment of high-output enterocutaneous fistulas with a vacuum-compaction device. A ten-year experience. World J Surg 2008; 32 (03) 430-435
    CrossrefPubMedGoogle Scholar
  • 22 Hyon SH, Martinez-Garbino JA, Benati ML, Lopez-Avellaneda ME, Brozzi NA, Argibay PF. Management of a high-output postoperative enterocutaneous fistula with a vacuum sealing method and continuous enteral nutrition. ASAIO J 2000; 46 (04) 511-514
    CrossrefPubMedGoogle Scholar
  • 23 Ollat D, Bouchard A, Tramond B, Nuzzaci F, Barbier O, Versier G. Vacuum-assisted closure: a low cost negative pressure system for wound management. Eur J Orthop Surg Traumatol 2009; 17: 505-509
    PubMedGoogle Scholar
  • 24 Draus Jr JM, Huss SA, Harty NJ, Cheadle WG, Larson GM. Enterocutaneous fistula: are treatments improving?. Surgery 2006; 140 (04) 570-576 , discussion 576–578
    CrossrefPubMedGoogle Scholar
  • 25 Nightingale JMD. The medical management of intestinal failure: methods to reduce the severity. Proc Nutr Soc 2003; 62 (03) 703-710
    CrossrefPubMedGoogle Scholar
  • 26 Olsen AK, Sjøgren P. Oral glycopyrrolate alleviates drooling in a patient with tongue cancer. J Pain Symptom Manage 1999; 18 (04) 300-302
    CrossrefPubMedGoogle Scholar
  • 27 Tscheng DZ. Sialorrhea - therapeutic drug options. Ann Pharmacother 2002; 36 (11) 1785-1790
    CrossrefPubMedGoogle Scholar
  • 28 Clark K, Lam LT, Gibson S, Currow D. The effect of ranitidine versus proton pump inhibitors on gastric secretions: a meta-analysis of randomised control trials. Anaesthesia 2009; 64 (06) 652-657
    CrossrefPubMedGoogle Scholar
  • 29 Clark K, Lam L, Currow D. Reducing gastric secretions--a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction?. Support Care Cancer 2009; 17 (12) 1463-1468
    CrossrefPubMedGoogle Scholar
  • 30 Lloyd DAJ, Gabe SM, Windsor ACJ. Nutrition and management of enterocutaneous fistula. Br J Surg 2006; 93 (09) 1045-1055
    CrossrefPubMedGoogle Scholar
  • 31 Nubiola-Calonge P, Badía JM, Sancho J, Gil MJ, Segura M, Sitges-Serra A. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output. Lancet 1987; 2 (8560): 672-674
    PubMedGoogle Scholar
  • 32 Nubiola P, Badia JM, Martinez-Rodenas F. , et al. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995. Ann Surg 1989; 210 (01) 56-58
    CrossrefPubMedGoogle Scholar
  • 33 Torres AJ, Landa JI, Moreno-Azcoita M. , et al. Somatostatin in the management of gastrointestinal fistulas. A multicenter trial. Arch Surg 1992; 127 (01) 97-99 , discussion 100
    CrossrefPubMedGoogle Scholar
  • 34 Scott NA, Finnegan S, Irving MH. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study. Acta Gastroenterol Belg 1993; 56 (3-4): 266-270
    PubMedGoogle Scholar
  • 35 Sitges-Serra A, Guirao X, Pereira JA, Nubiola P. Treatment of gastrointestinal fistulas with Sandostatin. Digestion 1993; 54 (Suppl. 01) 38-40
    CrossrefPubMedGoogle Scholar
  • 36 Sancho JJ, di Costanzo J, Nubiola P. , et al. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995; 82 (05) 638-641
    CrossrefPubMedGoogle Scholar
  • 37 Jamil M, Ahmed U, Sobia H. Role of somatostatin analogues in the management of enterocutaneous fistulas. J Coll Physicians Surg Pak 2004; 14: 237-240
    PubMedGoogle Scholar
  • 38 Leandros E, Antonakis PT, Albanopoulos K, Dervenis C, Konstadoulakis MM. Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas. Can J Gastroenterol 2004; 18 (05) 303-306
    PubMedGoogle Scholar
  • 39 Li-Ling J, Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg 2001; 88 (02) 190-199
    CrossrefPubMedGoogle Scholar
  • 40 Alivizatos V, Felekis D, Zorbalas A. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas. Hepatogastroenterology 2002; 49 (46) 1010-1012
    PubMedGoogle Scholar
  • 41 Gayral F, Campion JP, Regimbeau JM. , et al; Lanreotide Digestive Fistula. Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae. Ann Surg 2009; 250 (06) 872-877
    CrossrefPubMedGoogle Scholar
  • 42 Petrelli NJ, Rodriguez-Bigas M, Rustum Y, Herrera L, Creaven P. Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma. Cancer 1993; 72: 1543-1546
    CrossrefPubMedGoogle Scholar
  • 43 Vance ML, Harris AG. Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group. Arch Intern Med 1991; 151 (08) 1573-1578
    CrossrefPubMedGoogle Scholar
  • 44 Turégano F, García-Marín A. Anatomy-based surgical strategy of gastrointestinal fistula treatment. Eur J Trauma Emerg Surg 2011; 37 (03) 233-239
    CrossrefPubMedGoogle Scholar
  • 45 Bosscha K, van Vroonhoven TJ. Novel approach to the treatment of intestinal fistula in the inaccessible abdomen: transbursal end-to-side duodenogastrostomy. Br J Surg 1998; 85 (02) 276-278
    CrossrefPubMedGoogle Scholar
  • 46 Fazio VW, Coutsoftides T, Steiger E. Factors influencing the outcome of treatment of small bowel cutaneous fistula. World J Surg 1983; 7 (04) 481-488
    CrossrefPubMedGoogle Scholar
  • 47 Hollington P, Mawdsley J, Lim W, Gabe SM, Forbes A, Windsor AJ. An 11-year experience of enterocutaneous fistula. Br J Surg 2004; 91 (12) 1646-1651
    CrossrefPubMedGoogle Scholar
  • 48 Visschers RG, Olde Damink SW, Winkens B, Soeters PB, van Gemert WG. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg 2008; 32 (03) 445-453
    CrossrefPubMedGoogle Scholar
  • 49 Deitch EA, Winterton J, Li M, Berg R. The gut as a portal of entry for bacteremia. Role of protein malnutrition. Ann Surg 1987; 205 (06) 681-692
    CrossrefPubMedGoogle Scholar
  • 50 Kudsk KA. Beneficial effect of enteral feeding. Gastrointest Endosc Clin N Am 2007; 17 (04) 647-662
    CrossrefPubMedGoogle Scholar
  • 51 Teubner A, Morrison K, Ravishankar HR, Anderson ID, Scott NA, Carlson GL. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg 2004; 91 (05) 625-631
    CrossrefPubMedGoogle Scholar
  • 52 Mettu SR. Correspondence: Fistuloclysis can replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg 2004; 91: 1203
    PubMedGoogle Scholar
  • 53 Papanicolaou N, Mueller PR, Ferrucci Jr JT. , et al. Abscess-fistula association: radiologic recognition and percutaneous management. AJR Am J Roentgenol 1984; 143 (04) 811-815
    CrossrefPubMedGoogle Scholar
  • 54 Thomas HA. Radiologic investigation and treatment of gastrointestinal fistulas. Surg Clin North Am 1996; 76 (05) 1081-1094
    CrossrefPubMedGoogle Scholar
  • 55 Rao SR, Murthy KJ, Chandramouli C. Air as a negative contrast medium in the study of amebic liver abscess. Am J Gastroenterol 1973; 60 (05) 504-509
    PubMedGoogle Scholar
  • 56 Pickhardt PJ, Bhalla S, Balfe DM. Acquired gastrointestinal fistulas: classification, etiologies, and imaging evaluation. Radiology 2002; 224 (01) 9-23
    CrossrefPubMedGoogle Scholar
  • 57 August DA, Serrano D, Poplin E. “Spontaneous,” delayed colon and rectal anastomotic complications associated with bevacizumab therapy. J Surg Oncol 2008; 97 (02) 180-185
    CrossrefPubMedGoogle Scholar
  • 58 Losanoff JE, Basson MD. Percutaneous embolization of enterocutaneous fistulas. Dis Colon Rectum 2007; 50 (11) 2003-2004
    CrossrefPubMedGoogle Scholar
  • 59 Trecca A, Gaj F, Gagliardi G. Our experience with endoscopic repair of large colonoscopic perforations and review of the literature. Tech Coloproctol 2008; 12 (04) 315-321 , discussion 322
    CrossrefPubMedGoogle Scholar
  • 60 de Hoyos A, Villegas O, Sánchez JM, Monroy MA. Endoloops as a therapeutic option in colocutaneous fistula closure. Endoscopy 2005; 37 (12) 1258
    Article in Thieme ConnectPubMedGoogle Scholar
  • 61 Kumar R, Naik S, Tiwari N, Sharma S, Varsheney S, Pruthi HS. Endoscopic closure of fecal colo-cutaneous fistula by using metal clips. Surg Laparosc Endosc Percutan Tech 2007; 17 (05) 447-451
    CrossrefPubMedGoogle Scholar
  • 62 Shand A, Reading S, Ewing J. , et al. Palliation of a malignant gastrocolic fistula by endoscopic human fibrin sealant injection. Eur J Gastroenterol Hepatol 1997; 9 (10) 1009-1011
    CrossrefPubMedGoogle Scholar
  • 63 Rots WI, Mokoena T. Successful endoscopic closure of a benign gastrocolonic fistula using human fibrin sealant through gastroscopic approach: a case report and review of the literature. Eur J Gastroenterol Hepatol 2003; 15 (12) 1351-1356
    CrossrefPubMedGoogle Scholar
  • 64 Papavramidis ST, Eleftheriadis EE, Papavramidis TS, Kotzampassi KE, Gamvros OG. Endoscopic management of gastrocutaneous fistula after bariatric surgery by using a fibrin sealant. Gastrointest Endosc 2004; 59 (02) 296-300
    CrossrefPubMedGoogle Scholar
  • 65 Santos F, Campos J, Freire J, Andrade A, Távora I, Castelo HB. Enterocutaneous fistulas: an unusual solution. Hepatogastroenterology 1997; 44 (16) 1085-1089
    PubMedGoogle Scholar
  • 66 Lee YC, Na HG, Suh JH, Park I-S, Chung KY, Kim NK. Three cases of fistulae arising from gastrointestinal tract treated with endoscopic injection of Histoacryl. Endoscopy 2001; 33 (02) 184-186
    Article in Thieme ConnectPubMedGoogle Scholar
  • 67 Loungnarath R, Dietz DW, Mutch MG, Birnbaum EH, Kodner IJ, Fleshman JW. Fibrin glue treatment of complex anal fistulas has low success rate. Dis Colon Rectum 2004; 47 (04) 432-436
    CrossrefPubMedGoogle Scholar
  • 68 Avalos-González J, Portilla-deBuen E, Leal-Cortés CA. , et al. Reduction of the closure time of postoperative enterocutaneous fistulas with fibrin sealant. World J Gastroenterol 2010; 16 (22) 2793-2800
    CrossrefPubMedGoogle Scholar
  • 69 Truong S, Böhm G, Klinge U, Stumpf M, Schumpelick V. Results after endoscopic treatment of postoperative upper gastrointestinal fistulas and leaks using combined Vicryl plug and fibrin glue. Surg Endosc 2004; 18 (07) 1105-1108
    CrossrefPubMedGoogle Scholar
  • 70 Dalton D, Woods S. Successful endoscopic treatment of enterocutaneous fistulas by histoacryl glue. Aust N Z J Surg 2000; 70 (10) 749-750
    CrossrefPubMedGoogle Scholar
  • 71 Lisle DA, Hunter JC, Pollard CW, Borrowdale RC. Percutaneous gelfoam embolization of chronic enterocutaneous fistulas: report of three cases. Dis Colon Rectum 2007; 50 (02) 251-256
    CrossrefPubMedGoogle Scholar
  • 72 Khairy GE, al-Saigh A, Trincano NS, al-Smayer S, al-Damegh S. Percutaneous obliteration of duodenal fistula. J R Coll Surg Edinb 2000; 45 (05) 342-344
    PubMedGoogle Scholar
  • 73 Miranda LEC, Sabat BD, Carvalho EA. A low-output colocutaneous fistula healed by Surgisis anal plug. Tech Coloproctol 2009; 13 (04) 315-316
    CrossrefPubMedGoogle Scholar
  • 74 Girard S, Sideman M, Spain DA. A novel approach to the problem of intestinal fistulization arising in patients managed with open peritoneal cavities. Am J Surg 2002; 184 (02) 166-167
    CrossrefPubMedGoogle Scholar
  • 75 Sarfeh IJ, Jakowatz JG. Surgical treatment of enteric ‘bud’ fistulas in contaminated wounds. A riskless extraperitoneal method using split-thickness skin grafts. Arch Surg 1992; 127 (09) 1027-1030 , discussion 1030–1031
    CrossrefPubMedGoogle Scholar
  • 76 Jamshidi R, Schecter WP. Biological dressings for the management of enteric fistulas in the open abdomen: a preliminary report. Arch Surg 2007; 142 (08) 793-796
    CrossrefPubMedGoogle Scholar